StockData
Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR) stock

ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3035% above fair value
$43.11+0.12 (+0.28%)

Close on Nov 18, 2026Market cap $6.09BP/E –Yield –

Arrowhead Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Arrowhead Pharmaceuticals's total debt was $2.10M at Sep 30, 2018. For fiscal 2018 it was $2.10M, down 9.6% from the year before. The highest annual figure on record is $2.53M in fiscal 2016.

Annual total debt

PeriodPeriod endValueChange
FY2018Sep 30, 2018$2.10M-9.6%
FY2017Sep 30, 2017$2.33M-8.2%
FY2016Sep 30, 2016$2.53M+4966.9%
FY2013Sep 30, 2013$50.00K-94.0%
FY2012Sep 30, 2012$839.42K+38.3%
FY2011Sep 30, 2011$606.79K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2018CQ3 2018Sep 30, 2018$2.10M-9.6%
Q3 FY2018CQ2 2018Jun 30, 2018$2.16M-9.2%
Q2 FY2018CQ1 2018Mar 31, 2018$2.22M-8.9%
Q1 FY2018CQ4 2017Dec 31, 2017$2.27M-8.5%
Q4 FY2017CQ3 2017Sep 30, 2017$2.33M-8.2%
Q3 FY2017CQ2 2017Jun 30, 2017$2.38M–
Q2 FY2017CQ1 2017Mar 31, 2017$2.43M–
Q1 FY2017CQ4 2016Dec 31, 2016$2.48M–
Q4 FY2016CQ3 2016Sep 30, 2016$2.53M–

More Arrowhead Pharmaceuticals figures

See a number that looks wrong?